Ionis Pharmaceuticals (IONS) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Ionis Pharmaceuticals (IONS) over the last 16 years, with Q3 2025 value amounting to -$242.0 million.
- Ionis Pharmaceuticals' Other Gross PP&E Adjustments fell 4717.62% to -$242.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$242.0 million, marking a year-over-year decrease of 4717.62%. This contributed to the annual value of -$52.5 million for FY2024, which is 4173.15% up from last year.
- Per Ionis Pharmaceuticals' latest filing, its Other Gross PP&E Adjustments stood at -$242.0 million for Q3 2025, which was down 4717.62% from -$163.9 million recorded in Q2 2025.
- Ionis Pharmaceuticals' 5-year Other Gross PP&E Adjustments high stood at $153.1 million for Q4 2021, and its period low was -$242.0 million during Q3 2025.
- Its 5-year average for Other Gross PP&E Adjustments is -$130.8 million, with a median of -$164.4 million in 2024.
- In the last 5 years, Ionis Pharmaceuticals' Other Gross PP&E Adjustments plummeted by 17518.28% in 2022 and then skyrocketed by 4173.15% in 2024.
- Quarter analysis of 5 years shows Ionis Pharmaceuticals' Other Gross PP&E Adjustments stood at $153.1 million in 2021, then plummeted by 175.18% to -$115.1 million in 2022, then grew by 21.68% to -$90.1 million in 2023, then surged by 41.73% to -$52.5 million in 2024, then tumbled by 360.78% to -$242.0 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$242.0 million for Q3 2025, versus -$163.9 million for Q2 2025 and -$159.3 million for Q1 2025.